相关实验视频

Updated: Jan 16, 2026

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on: October 15, 2018

网氨酸和甲酸协同作用,通过TET2激活来抑制髓性白血病

Tiffany E Leesang¹, John P Brabson¹, Yoon Sing Yap¹

¹University of Miami, Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL 33136, USA; Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.

|October 2, 2025

概括

全转录氨酸 (ATRA) 与甲酸盐结合,增强了十-十一转位2 (TET2) 活性,促进骨髓性白血病细胞分化,并在临床前模型中改善生存率.

科学领域:

生物化学生物化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

增强十-十一转位2 (TET2) 活性可以阻碍骨髓瘤恶性瘤的进展.
由于药理动力学限制和需要进行染色质重塑,单独的亚斯科伯酸盐可能无法充分激活恶性细胞中的TET2.

研究的目的:

确定一种用于增强髓性白血病中TET2活性的新机制.
调查全转网红酸 (ATRA) 和酸盐对TET2激活和骨髓分化的协同作用.

主要方法:

在骨髓性白血病细胞中通过视网膜酸受体α (RARA) 调查ATRA诱导的TET2转录.
评估了ATRA和甲酸盐对DNA基甲基化和染色质重塑的联合作用.
使用了缺少Tet1/2/3的小鼠和人类急性髓性白血病 (AML) 模型.

主要成果:

ATRA诱导RARA介导的TET2转录,与酸盐协同作用,以增强DNA基甲基化和染色质重塑.
联合ATRA和甲酸盐治疗有效诱导分化并以TET2-依赖的方式抑制白血病干细胞自我更新.
组合疗法使AML细胞在体内对向治疗敏感,从而改善了存活率.

结论:

通过RARA介导的转录,ATRA增强了TET2活性,与酸盐协同工作.
亚特拉和甲酸盐的组合是促进TET2功能的有希望的策略,用于治疗骨髓瘤恶性瘤.
这种方法显示出增强分化和克服AML治疗耐药性的潜力.

关键词:

5hmCC 5hmCC是指5hmC的数值,它是指5hmC的数值.CP: 癌症癌症癌症科普:基因组学基因组学在TET2的基础上.阿斯科伯酸盐是一种酸盐.差异化疗法是一种差异化疗法.骨髓性白血病是一种白血病.网红酸是什么意思网红酸是什么意思

更多相关视频

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.